KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.83 $2.63 Friday, 26th Apr 2024 CGEN stock ended at $1.92. This is 1.05% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.74% from a day low at $1.86 to a day high of $1.98.
90 days $1.83 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
Jun 05, 2023 $1.05 $1.17 $1.04 $1.12 1 062 237
Jun 02, 2023 $1.08 $1.10 $1.03 $1.05 517 605
Jun 01, 2023 $1.00 $1.04 $0.94 $1.03 474 642
May 31, 2023 $1.01 $1.06 $1.01 $1.02 337 604
May 30, 2023 $1.08 $1.12 $1.04 $1.06 522 767
May 26, 2023 $1.14 $1.18 $1.00 $1.06 2 795 350
May 25, 2023 $0.99 $1.00 $0.92 $0.96 840 315
May 24, 2023 $0.84 $0.95 $0.83 $0.93 1 158 140
May 23, 2023 $0.81 $0.88 $0.80 $0.82 1 888 219
May 22, 2023 $0.760 $0.84 $0.750 $0.80 460 809
May 19, 2023 $0.760 $0.780 $0.755 $0.760 231 248
May 18, 2023 $0.770 $0.80 $0.760 $0.760 148 037
May 17, 2023 $0.772 $0.776 $0.716 $0.769 280 111
May 16, 2023 $0.797 $0.797 $0.700 $0.770 358 654
May 15, 2023 $0.81 $0.88 $0.755 $0.81 624 277
May 12, 2023 $0.740 $0.794 $0.740 $0.740 418 120
May 11, 2023 $0.780 $0.780 $0.710 $0.750 322 323
May 10, 2023 $0.690 $0.768 $0.690 $0.750 790 901
May 09, 2023 $0.669 $0.720 $0.640 $0.670 334 476
May 08, 2023 $0.620 $0.680 $0.620 $0.665 229 727
May 05, 2023 $0.646 $0.670 $0.630 $0.630 160 300
May 04, 2023 $0.614 $0.646 $0.610 $0.630 132 682
May 03, 2023 $0.620 $0.638 $0.595 $0.629 124 630
May 02, 2023 $0.590 $0.620 $0.571 $0.610 136 535
May 01, 2023 $0.600 $0.623 $0.553 $0.565 300 688
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT